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ABSTRACT
Frailty, a measure of physiologic reserve, is associated with poor outcomes and mortality among kidney 
transplant (KT) candidates and recipients. There are no national estimates of frailty in this population, 
which may help patient counseling and resource allocation at transplant centers. We studied 4,616 KT 
candidates and 1,763 recipients in our multi-center prospective cohort of frailty from 2008-2018 with 
Fried frailty measurements. Using SRTR data (KT candidates=560,143 and recipients=243,508), we 
projected the national prevalence of frailty (for KT candidates and recipients separately) using 
standardization through inverse probability weighting, accounting for candidate/recipient, donor, and 
transplant factors. In our multi-center cohort, 13.3% KT candidates were frail at evaluation; 8.2% of 
LDKT recipients and 17.8% of DDKT recipients were frail at transplantation. Projected nationally, our 
modeling strategy estimated 91,738 KT candidates or 16.4% (95%CI:14.4-18.4%) of all KT candidates 
during the study period were frail, and 34,822 KT recipients or 14.3% (95%CI:12.3-16.3%) of all KT 
recipients were frail (LDKT=8.2%; DDKT=17.8%). Given its estimated national prevalence, transplant 
programs should consider assessing frailty during KT evaluation to improve patient counseling and 
resource allocation along with identification of recipients at risk for poor outcomes. 
INTRODUCTION
Frailty is characterized by decreased physiologic reserve and resistance when confronted with a stressor, 
such as transplantation. The Fried physical frailty phenotype, a common measurement of frailty, is 
comprised of unintentional weight loss, slowed walking speed, decreased grip strength, decreased 
physical activity, and exhaustion, and was initially identified in community-dwelling older adults (1). 
Based on previous cohort studies, frailty is prevalent in 12-20% of kidney transplant (KT) candidates and 
is associated with decreased listing for KT (2), waitlist mortality (2, 3), decreased transplantation rates 
after listing (2), and poor health-related quality of life (4). Furthermore, frailty in KT recipients is 
associated with poor outcomes following KT such as delirium (5), longer length of stay (6), early hospital 
readmission (7), immunosuppression intolerance (8), poor health-related quality of life (9), cognitive 
decline (10), and mortality (11). Yet these estimates are from multi-center cohort studies, and national 
prevalence estimates of frailty may vary from these studies due to differences in KT candidate and 
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management, resource allocation, and planning at transplant centers, as well as with patient counseling 
regarding waiting time and outcomes prior to KT. 
Frailty is not commonly assessed at the time of evaluation, transplant, or collected in national registries, 
despite its association with poor outcomes in KT candidates and recipients (12). In 2018 in the United 
States, 94,970 adults were listed for KT and 21,167 underwent KT (13), and likely a large percentage of 
those KT recipients were frail. Additionally, frailty is more common in older (age≥65) KT candidates (2, 3) 
and KT recipients (14), and the number of older adults undergoing KT is increasing over time, with more 
than 19% of KT recipients over the age of 65 (13, 15). Thus, national estimates of frailty across all states, 
donor service areas (DSAs), and transplant centers may help guide interventions to reduce or lessen the 
burden of frailty in the growing population of vulnerable KT candidates and recipients.
Understanding the prevalence of frailty among KT candidates and recipients can inform candidate 
expectations and waitlist management at centers across the United States. In this study, we estimated 
the prevalence of frailty in a prospective, longitudinal, multi-center cohort of KT candidates and 
recipients and developed a predictive statistical model using characteristics captured by the national 
transplant registry. Then, using a novel statistical approach, we estimated the national prevalence of 
frailty among transplant candidates and recipients in the United States over the two decades. Finally, we 
explored geographic difference in the prevalence of frailty across the United States.
METHODS
Prospective Cohort Data Source: KT Candidates 
This study used data from a prospective, longitudinal multi-center cohort study at the Johns Hopkins 
Hospital (N=2,217), Baltimore, Maryland; the University of Michigan Hospital (N=97), Ann Arbor, 
Michigan; and the Methodist Specialty and Transplant Hospital (N=2,217), San Antonio, Texas, and has 
been described elsewhere (7, 16-18). Briefly, study participants were enrolled prior to KT and consented 
to medical record abstraction to allow for the identification of demographics and co-morbidities. KT 
candidates underwent a battery of exams to assess frailty (as described below) at KT evaluation in clinic. 
The clinical and research activities being reported are consistent with the Declaration of Helsinki and 
Declaration of Istanbul. The Institutional Review Boards of Johns Hopkins Hospital, the University of 
Michigan, and the Methodist Specialty and Transplant Hospital approved this study, and all participants 
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Prospective Cohort Data Source: KT Recipients 
The data for KT recipients was collected from the same longitudinal, prospective cohort studies at Johns 
Hopkins Hospital (n=952), University of Michigan (n=82), and the Methodist Specialty and Transplant 
Hospital (n=729). At Johns Hopkins Hospital and the University of Michigan, study participants were 
enrolled at the time of KT and consented to medical record abstraction to allow for the identification of 
demographics and co-morbidities. KT recipients underwent a battery of exams to assess frailty (as 
described below) at admission for KT. At the Methodist Specialty and Transplant Hospital, participants 
were enrolled at KT evaluation and frailty was assessed at every visit prior to KT; the measure of frailty 
prior to KT was used to estimate the prevalence of frailty among KT recipients.
National Registry Data Source
This study also used data from the Scientific Registry of Transplant Recipients (SRTR) external release 
made available in December 2018. The SRTR data system includes data on all donors, waitlist 
candidates, and transplant recipients in the United States (US), submitted by members of the Organ 
Procurement and Transplantation Network (OPTN), and has been previously described (19). The Health 
Resources and Services Administration (HRSA), U.S. Department of Health and Human Services provides 
oversight to the activities of the OPTN and SRTR contractors. Using SRTR, we identified 560,143 adult 
(age≥18) candidates listed and 243,508 adult recipients who underwent KT between January 2000 and 
June 2018 to include the KT listing dates of candidates at the three prospective cohort centers. 
Frailty
We studied the Fried physical frailty phenotype as defined (1) in older adults as well as in end-stage 
renal disease and KT populations (2, 4-8, 10, 11, 17, 20-26). The Fried physical frailty phenotype was 
based on 5 components: shrinking (self-report of unintentional weight loss of more than 10 pounds in 
the past year based on dry weight); weakness (grip-strength below an established cutoff based on 
gender and BMI); exhaustion (self-report); low activity (Kcals/week below an established cutoff); and 
slowed walking speed (walking time of 15 feet below an established cutoff by gender and height) (1). 
Each of the 5 components was scored as 0 or 1 representing the absence or presence of that 
component. The aggregate frailty score was calculated as the sum of the component scores (range 0-5); 
frail was defined as a score of ≥3, prefrail as a score of 2, and nonfrail as a score of <2. The physicians at 















This article is protected by copyright. All rights reserved
time of evaluation, but the physicians at Methodist Specialty and Transplant Hospital were aware of the 
frailty assessments at the time of evaluation. 
Estimating National Prevalence
To estimate the national prevalence of frailty, we mapped data from our prospective cohort to the 
national transplant population using variables captured by both databases. We used standardization 
using inverse probability of selection weights (IPSW). Standardization is a common approach in public 
health that uses known characteristics about a target population to inform estimation in a sampled 
population or vice versa. Weighting approaches to standardization allow for additional covariates to be 
considered.
We used a two-stage approach to estimate the national prevalence of frailty using IPSW. This method 
seeks to provide unbiased estimates by adjusting for variables that may have affected the selection of 
our study population relative to the general transplant population. The first stage calculated restricted 
IPSW weights using baseline characteristics. For candidates, we adjusted for female sex, African-
American race, Hispanic ethnicity, age at listing, time on dialysis, college education, body mass index 
(BMI), hypertension status, history of previous transplant, employment status, public insurance status, 
and PRA at listing. For recipients, we adjusted for female sex, African-American race, Hispanic ethnicity, 
age at transplant (splines with knots at 35 and 65), ≥2 years on dialysis, college education, BMI, 
hypertension status, history of previous transplant, employment status, public insurance status, PRA at 
transplant, and donor BMI. Potential variables were selected based on prior literature and parsimonious 
models were built to maximize the Akaike information criterion (AIC) and Bayesian information criterion 
(BIC). These weights were then restricted to the range 10% to 90% to avoid bias due to extreme weights 
(27) and converted to inverse probability of selection weights. The second stage used linear risk 
regression to examine the prevalence of frailty weighted by the IPSW. 
Frailty prediction model 
We constructed a prediction model for frailty using data from our prospective cohort. The model 
building approach maximized AUC and adjusted for recipient (age, sex, African-American race, Hispanic 
ethnicity, diabetes, hypertension, history of transplant, college education, PRA at transplant, preemptive 
transplant, years on dialysis, BMI, public insurance status, and employment status), donor (age, sex, 
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and eGFR), transplant (HLA mismatch, year of transplant, cold ischemia time), and outcome (all-cause 
graft loss) characteristics. Separate models were used for KT candidates and recipients; donor and 
outcome variables were only included in the KT recipient model. 
Visualizing Prevalence Differences
Using the national prevalence estimates, we estimated the number of frail and prefrail candidates and 
transplant recipients across 58 DSAs and across 288 transplant centers. We estimated the ratio of the 
number of frail recipients divided by the number of frail candidates as a measure of access to 
transplantation for those that are frail (ratio >1 indicates greater access) for each DSA. We then 
compared the frail transplant recipient/candidate ratio in each DSA to the median frail transplant 
recipient/candidate ratio to demonstrate differences in access by geographic boundary. We presented a 
similar measure for candidates and recipients that are prefrail. 
Statistical Analysis
For participants in the prospective cohort, differences in recipient, donor, and transplant characteristics 
by frailty status were assessed using the χ2 (categorical variables) and Mann-Whitney rank-sum 
(continuous variables) tests. We used a two-sided α of 0.05 to indicate a statistically significant 
difference. All analyses were performed using Stata 15/MP for Linux (College Station, Texas).
Sensitivity analyses
We built prediction models that were used to inform a multiple imputation approach. All models were 
run after multiple imputation for baseline characteristics. Conceptually, we used multiple imputation by 
chained equation (MICE) to predict the frailty status of individuals in the general transplant population 
by treating the frailty status of those not in our prospective cohort as missing-at-random. A prediction 
model for frailty was built in our prospective cohort to maximize area-under-the-curve (AUC). The 
variables from this prediction model were then used to generate 100 imputed datasets (after 10 run-in 
datasets) using MICE and Rubins’ rules for pooled estimation. 
Additionally, we estimated the national prevalence of frailty among kidney transplant candidates, living 
donor kidney transplant (LDKT) recipients, and deceased donor kidney transplant (DDKT) recipients 
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Alabama, Arkansas, Georgia, Kentucky, Louisiana, Mississippi, North Carolina, South Carolina, and 
Tennessee.
We also compared the distribution of impairment characterized by the Karnofsky Performance Score 
(KPS) and frailty across DSAs among KT candidates and KT recipients using tetrachoric correlation. KPS 
impairment was defined as at or below 70%.
RESULTS
Prospective Cohort Characteristics 
Among 4,616 KT candidates in our prospective cohort, 612 (13.3%) were frail. Frail participants were 
more likely to be older (55.0 years vs. 52.0 years, p<0.001), African-American (41.2% vs. 25.8%, 
p<0.001), have diabetes (41.3% vs. 35.9%, p<0.01), and have a history of previous transplant (19.8% vs. 
15.1%, p<0.01) and less likely to be Hispanic (22.4% vs. 37.5%, p<0.001) and employed at the time of 
listing (24.8% vs. 37.1%, p<0.001) compared to nonfrail participants (Table 1). 
Among the 817 living donor kidney transplant (LDKT) recipients in our prospective cohort, 67 (8.2%) 
were frail. Frail participants were less likely to be Hispanic (17.9% vs. 35.3%, p<0.01) but were similar to 
nonfrail participants in other characteristics (Table 2). 
Among the 946 deceased donor kidney transplant (DDKT) recipients in our prospective cohort, 168 
(17.8%) were frail. Frail participants were more likely to be African-American (52.4% v. 39.2%, p<0.01), 
older (59 years vs. 54 years, p<0.001), have higher BMI (29.6 v. 28.1, p=0.03), and have HCV infection 
(17.4% vs. 7.4%, p<0.001) and were less likely to be Hispanic (4.8% vs. 26.3%, p<0.001) or have public 
insurance (59.5% vs. 72.0%, p<0.01) at the time of KT (Table 3) compared to nonfrail participants. 
Additionally, frail DDKT recipients were more likely to receive higher median KDPI donors than nonfrail 
DDKT recipients (52.8 vs. 42.7, p<0.001) and have a longer cold ischemia time (25.0 hours vs. 22.1 hours, 
p=0.04). 
National Prevalence of Frailty
In our prospective cohort, the frailty prediction model had an AUC of 0.731 for KT recipients (Figure 1). 
560,143 KT candidates were listed during our study period (01/2000-06/2018). We estimated that 16.4% 
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total of 243,508 transplant recipients during our study period, and we estimated that 14.3% (N=34,822, 
95%CI: 12.3-16.3%) of transplant recipients were frail; 8.2% of LDKT recipients and 17.8% of DDKT 
recipients were frail.
Geographic Distribution 
Among KT candidates, the median (IQR) prevalence of frailty across 58 DSAs was 13.9% (12.6%-14.6%) 
and across 288 transplant centers was 13.4% (11.6%-14.7%). Among KT recipients, the median (IQR) 
prevalence of frailty across 58 DSAs was 18.8% (18.0%-20.5%) and across 288 transplant centers was 
18.2% (16.4%-20.5%). 
Based on our prediction model for frailty, we estimated the number of frail and prefrail candidates 
(Figure 2) and recipients (Figure 3) by DSA. The highest concentration of prefrail and frail candidates 
were in California and New York. Our estimates also suggest variation in the transplant/candidate ratio 
for frail and prefrail individuals by DSA (Figure 4). The lowest access to transplant in frail candidates 
were in California, Texas, Alabama, and Georgia. 
Sensitivity analyses
Using MICE, we estimated that 20.5% (N=49,904, 95%CI: 14.5-26.5%) of transplant recipients were frail, 
and we estimated that 16.4% (N=92,003, 95% CI: 15.4-17.5%) of transplant candidates were frail. 
After exclusion of states in the Stroke Belt, the national prevalence of frailty estimates among KT 
candidates, LDKT recipients, and DDKT recipients were similar to our primary results using IPSW and 
MICE (Supplemental Table 1A, 1B). 
Among our KT candidate cohort, 30 of 612 frail candidates had KPS impairment, and among our KT 
recipient cohort, 7 of 235 frail recipients had KPS impairment. Among national KT candidates, 24.3% had 
KPS impairment. KPS impairment poorly correlated with frailty measurements for KT candidates in our 
cohort (rho 0.07). Furthermore, among national KT recipients, 26.8% had KPS impairment. KPS 
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Nationally, we estimated that 16.4% of KT candidates were frail, and 14.3% of KT recipients were frail 
from 2000-2018; 8.2% of LDKT recipients and 17.8% of DDKT recipients were frail. Furthermore, the 
prevalence of frailty among KT recipients and candidates varies across the United States. In our three-
center prospective cohort study of frailty in more than 6,000 participants, we found that 8.2% of LDKT 
recipients, and 17.8% of DDKT recipients were frail. Frail KT candidates were more likely to be older 
(p<0.001) and African-American (p<0.001) and less likely to be Hispanic (p<0.001). Similarly, frail DDKT 
recipients were more likely to be older (p<0.001) and African-American (p<0.01) and less likely to be 
Hispanic (p<0.001). 
Our finding that 16.4% of KT candidates were frail from national estimates were lower than those seen 
in other studies of hemodialysis patients using the Fried physical frailty phenotype with modification for 
weight loss (30-60% frail) (28, 29). However, this finding is not surprising considering that frail 
participants have nearly a 2-fold decreased chance of being listed for KT at evaluation compared to 
nonfrail participants . Additionally, our findings that frail participants were more likely to be older and 
have diabetes were similar to findings in the aforementioned study of hemodialysis patients (28). 
Identification of frail candidates at evaluation can help with patient counseling with regard to poor 
waitlist outcomes such as increased waitlist mortality and lower rate of KT (2), and also identify those 
who may benefit from closer follow-up and interventions. 
Additionally, using national registry data, we estimated that 8.2% of LDKT recipients and 17.8% of DDKT 
recipients in the US were frail at the time of transplant. Our results highlight the importance of 
identification of recipients at the time of transplant, given that one in five KT recipients will be at an 
increased odds of delirium (5) and longer length of stay (6), increased risk of delayed graft function (21), 
early hospital readmission (7), immunosuppression intolerance (8), cognitive decline (10), and mortality 
(11). Identification of these vulnerable patients can potentially help clinicians target those patients to 
mitigate poor outcomes after KT (2), and quantifying the national prevalence of frailty in kidney 
transplant candidates and recipients is important for resource allocation planning.
Strengths of this study include a large sample of KT candidates and recipients from three transplant 
centers and prospective cohort study of frailty. Additionally, the use of the novel measurement of frailty 
and national projections to estimate national prevalence are not currently possible through use of 
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limitation is the selection bias of participants who were referred from the community to the three 
transplant centers; however, we have no way to measure frailty in participants who were not referred 
for evaluation. Furthermore, there is a selection bias of who is referred and listed for transplantation, 
but the goal of our study was to inform decision-making at two distinct times for two distinct 
populations: at KT evaluation/listing for candidates and at admission for KT for recipients. Another 
notable limitation is that our national estimates may not be accurate given the prospective study 
population characteristics, and these should be noted as estimates. However, demographics between 
the three transplant centers are quite different (age, race, time on dialysis, living donor) which is a 
strength of this study (2).  
In conclusion, we estimated that 16.4% of KT candidates and 14.3% of KT recipients in the United States 
were frail from 2000-2018, and that the prevalence of frailty in KT candidates and recipients varied by 
geographic location. Given the high prevalence of frailty, transplant programs should consider assessing 
frailty during KT evaluation to improve informed consent and identify candidates for pre-KT 
interventions. Our findings can encourage centers to include frailty as part of their evaluation and help 
identify a vulnerable population of patients that may benefit from potential interventions like 
prehabilitation (30).
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FIGURE LEGEND
Figure 1. Prediction model performance (AUC = 0.731) for frailty among kidney transplant recipients.
Figure 2. Number of (A) prefrail and (B) frail KT candidates by donor service area from 2000-2018.
Figure 3. Number of (A) prefrail and (B) frail kidney transplant recipients by donor service area from 
2000-2018.
Figure 4. Number of (A) prefrail and (B) frail percentage difference from median transplant/candidate 
ratio to assess access to transplantation for among frail and nonfrail candidates from 2000-2018. The 
lowest access to transplant in frail candidates were in California, Texas, Alabama, and Georgia.
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Table 1. Characteristics of prospective cohort of kidney transplant candidates listed from 2000-2018 by frailty status 
(n=4,616).
Not Frail Pre-frail Frail p
N (%) 2862 (62.0%) 1142 (24.7%) 612 (13.3%)
Recipient Characteristics
Age at Listing* 52.0 (42.0-60.0) 54.0 (44.0-62.0) 55.0 (45.0-63.0) <0.001
Female, % 39.1 41.1 41.3 0.3
African-American, % 25.8 31.3 41.2 <0.001
Hispanic, % 37.5 30.8 22.4 <0.001
BMI, kg/m2* 29.1 (25.1-33.3) 29.6 (25.3-33.5) 29.5 (25.3-33.5) 0.7
Dialysis vintage, years* 1.0 (0.4-2.4) 1.0 (0.5-2.4) 0.9 (0.4-2.2) 0.2
College educated, % 55.8 52.9 53.8 0.4
Employed, % 37.1 30.5 24.8 <0.001
Public insurance, % 52.0 58.2 56.2 0.05
Diabetes, % 35.9 38.4 41.3 <0.01
Hypertension, % 23.6 23.4 24.7 0.6
Previous transplant, % 15.1 17.8 19.8 <0.01
PRA>80 at listing, % 1.4 1.2 2.3 0.1
* Median (interquartile range)
Table 2. Characteristics of prospective cohort of living donor kidney transplant recipients from 2008-2018 
by frailty status (n=817). 
Not Frail Prefrail Frail P value
N (%) 574 (70.3%) 176 (21.5%) 67 (8.2%)
Recipient Characteristics
Age, years* 50.0 (38.0-60.0) 51.0 (40.0-62.0) 53.0 (41.0-60.0) 0.4
Female, % 40.5 46.6 46.3 0.4
African-American, % 10.8 14.8 19.4 0.03
Hispanic, % 35.3 28.4 17.9 <0.001
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Dialysis vintage, years* 0.5 (0.0-1.9) 0.7 (0.0-2.4) 0.9 (0.0-3.1) 0.1
HCV, % 2.5 1.1 0 0.2
College educated, % 67.9 65.7 70.8 0.6
Employed, % 45.8 46 47.0 0.9
Public insurance, % 42.0 40.9 41.8 1.0
Diabetes, % 27.6 28.4 31.3 0.5
Hypertension, % 16.0 13.6 11.9 0.4
Previous transplant, % 14.5 19.9 20.9 0.2
PRA>80 at listing, % 20.1 20 15.4 0.5
Donor Characteristics
Age, years* 42.0 (33.0-52.0) 44.5 (35.5-52.0) 45.0 (35.0-54.0) 0.1
Female, % 64.8 63.1 64.2 0.9
African-American, % 7.6 10.2 13.4 0.09
Hispanic, % 32.3 25.6 17.9 0.01
BMI, kg/m2* 27.3 (24.1-30.5) 26.9 (23.9-29.7) 26.9 (23.9-30.1) 0.5
eGFR* 104.4 (87.7-118.3) 103.0 (88.7-117.3) 99.9 (88.0-112.3) 0.3
Biologically related, % 39.9 44.3 32.8 0.3
Transplant Characteristics
ABO Incompatible, % 5.5 6.8 6 0.9
Zero HLA mismatch, % 5.9 4.6 4.5 0.6
Cold ischemia time, hours* 1.3 (1.1-1.9) 1.3 (1.0-2.0) 1.6 (1.0-4.0) 0.02
BMI= body mass index, HCV= hepatitis c virus, PRA= panel reactive antibody, GFR= glomerular filtration rate, 
HLA= human leukocyte antigen
 * Median (interquartile range)
Table 3. Characteristics of prospective cohort of deceased donor kidney transplant recipients from 2008-2018 
by frailty status (n=946).















This article is protected by copyright. All rights reserved
N 533 (56.3%) 245 (25.9%) 168 (17.8%)
Recipient Characteristics
Age, years* 54.0 (42.0-62.0) 58.0 (46.0-64.0) 59.0 (50.0-66.5) <0.001
Female, % 37.4 37.6 40.5 0.5
African-American, % 39.2 42.9 52.4 <0.01
Hispanic, % 26.3 15.5 4.8 <0.001
BMI, kg/m2* 28.1 (24.5-32.0) 28.7 (25.1-32.4) 29.6 (25.3-33.2) 0.03
Dialysis vintage, years* 4.0 (1.8-6.6) 3.0 (1.3-6.2) 2.8 (0.9-4.9) <0.001
HCV, % 7.9 11.5 17.4 <0.001
College educated, % 54.8 55.9 55.2 0.9
Employed, % 32.2 34.2 25 0.07
Public insurance, % 72.0 65.3 59.5 <0.01
Diabetes, % 25.4 26.1 24.4 0.8
Hypertension, % 34.2 32.7 37.5 0.4
Previous transplant, % 16.7 17.1 12.5 0.2
PRA>80 at listing, % 13.2 11.8 13.9 0.8
Donor Characteristics
Age, years* 34.0 (23.0-47.0) 35.0 (25.0-50.0) 36.0 (26.0-49.0) 0.10
Female, % 41.1 42.4 41.7 0.9
African-American, % 18.0 22 20.8 0.4
Hispanic, % 19.2 14.7 5.4 <0.001
BMI, kg/m2* 26.6 (23.0-31.2) 26.8 (23.3-32.3) 25.7 (23.0-30.0) 0.3
KDPI* 42.7 (23.7-63.5) 46.1 (27.9-67.7) 52.8 (36.8-71.1) <0.001
Transplant Characteristics
Zero HLA mismatch, % 5.1 4.1 5.4 0.9
Cold ischemia time, hours* 22.1 (15.3-29.1) 24.0 (16.3-30.0) 25.0 (15.8-32.0) 0.04
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Table 4. National estimates of frailty among kidney transplant candidates, living donor kidney 
transplant (LDKT) recipients, and deceased donor kidney transplant (DDKT) recipients. Predicted 
national prevalence was estimated using inverse-probability of selection weights (IPSW). 
N IPSW (95% Confidence 
Interval)*
KT candidates 560,143 16.4% (14.4%-18.4%)
LDKT 81,322 8.2% (6.3%-10.1%)
DDKT 162,186 17.8% (15.3%-20.2%)















This article is protected by copyright. All rights reserved














0.00 0.25 0.50 0.75 1.00
1 - Specificity
Area under ROC curve = 0.7280
Frailty Prediction in Complete Cases (N=545)
















This article is protected by copyright. All rights reserved
(B)
































This article is protected by copyright. All rights reserved
Figure 4. Number of (A) prefrail and (B) frail percentage difference from median transplant/candidate ratio to assess 
access to transplantation for among frail and nonfrail candidates from 2000-2018. The lowest access to transplant in frail 
candidates were in California, Texas, Alabama, and Georgia.
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